Related by context. Frequent words. (Click for all words.) 84 Phase 1b 80 Phase IIa 80 Phase 2a 80 Phase 2b trial 79 Phase 2b study 79 Phase IIb 79 Phase III clinical 78 Phase IIb trial 78 Phase 2b clinical 78 Phase IIa trial 78 Phase III 78 Phase 2a clinical 77 Phase IIa clinical 77 Phase IIb clinical 75 pivotal Phase III 75 dose escalation study 75 Phase 2b 74 Phase II 73 dose escalation 72 Phase III clinical trials 71 Phase III trials 71 randomized Phase 71 pivotal Phase 69 clinical trial 69 AP# [003] 69 IMGN# 68 tolerability 68 placebo controlled 68 perifosine 68 IND enabling 68 PRX # 67 Marqibo 67 preclinical 67 RDEA# 67 preclinical studies 66 MGCD# [001] 66 Phase 66 carfilzomib 66 ARRY 66 ofatumumab 66 mipomersen 66 XL# [003] 66 safety tolerability 66 initiate Phase 66 daclizumab 66 RG# [001] 65 pharmacokinetic 65 clinical trials 65 ISIS # 65 blind randomized placebo 65 IDX# 64 investigational compound 64 HspE7 64 MDV# 64 voreloxin 64 INCB# [002] 64 pharmacodynamics 64 ASA# 64 MGCD# [002] 64 CYT# 64 double blind placebo 63 randomized placebo controlled 63 pharmacokinetics 63 CRx 63 NDA submission 63 T DM1 63 randomized clinical 63 bavituximab 63 unblinded 62 Locteron 62 AEZS 62 multicenter 62 FOLOTYN 62 laquinimod 62 oral formulation 62 AZD# 62 pharmacodynamic 62 picoplatin 62 randomized double 61 monotherapy 61 investigational drug 61 tivozanib 61 Alpharadin 61 DSMB 61 dosing regimens 61 CUDC 61 ADX# 60 LEVADEX 60 randomized controlled 60 immunogenicity 60 eculizumab 60 tolerability profile 60 Bronchitol 60 sunitinib 60 LymphoStat B 60 orally administered 60 APD# 60 ALKS 60 brentuximab vedotin 60 elesclomol 60 Opexa